High doses of ARA C in the treatment of acute leukemia
Lobato-Mendizábal, E.; Ruiz-Argüelles, G.J.; Marín-López, A.
Sangre 34(1): 78-79
1989
ISSN/ISBN: 0036-4355 PMID: 2711290 Document Number: 340225
Document emailed within 1 workday
Related Documents
Latagliata, R.; Petti, M.C.; Spiriti, M.A.; Meloni, G.; Sgadari, C.; Torromeo, C.; Vegna, M.L.; Mandelli, F. 1990: High doses of ara-C and m-AMSA in the treatment of refractory acute non lymphocytic leukemia Haematologica 75(3): 249-251Leone, G.; Mango, G.; Alfano, G. 1978: Disseminated intravascular coagulation in acute promyelocytic leukemia. Possibility of treatment with glucocorticoids at high doses Nouvelle Revue Francaise d'Hematologie 20(3): 395-401
Zhao, S.C. 1987: Chemotherapy of medium-to-large doses in the treatment of acute leukemia: report of 16 cases Zhonghua Yi Xue Za Zhi 67(7): 371-373
Cetkovský, P.; Koza, V.; Cepelák, V.; Vít, L. 1994: Hemostasis in patients with acute leukemia treated with high doses of cytosine-arabinoside: the effect of chemotherapy and infectious complications on hemostasis Vnitrni Lekarstvi 40(11): 730-734
Dencker, S.J. 1979: Treatment with high doses of neuroleptics in the acute phase of mental diseases Acta Psiquiatrica y Psicologica de America Latina 25(2): 157-160
Dłuzniewska, A.; Balwierz, W.; Balcerska, A.; Chybicka, A.; Kamieńska, E.; Karolczyk, G.; Karpińska-Derda, I.; Krawczuk-Rybak, M.; Kowalczyk, J.R.; Lewandowska, D.; Maciejka-Kapuścińska, L.; Kołtano, S.; Malinowska, I.; Matysiak, Mł.; Mikołajczyk, M.; Mizia-Malarz, A.; Muszyńska-Rosłan, K.; Niedźwiedzki, M.; Pohorecka, J.; Sikorska-Fic, B.; Sobol, G.; Sońta-Jakimczyk, D.; Tomaszewska, R.; Urasiński, T.; Wachowiak, J.; Wieczorek, M.; Wójcik, B.; Wysocki, M. 2010: Treatment failure in children with acute myelocytic leukemia: over 25-year experience of Polish Pediatric Leukemia/Lymphoma Study Group with four consecutive unified treatment protocols for childhood acute myelocytic leukemia Przeglad Lekarski 67(6): 366-370
Wang, J.J.; Freeman, A.I.; Sinks, L.F. 1976: Treatment of acute lymphocytic leukemia by high-dose intravenous methotrexate Cancer Research 36(4): 1441-1444
Van Echo, D.A.; Wiernik, P.H.; Aisner, J. 1980: High-dose VP 16-213 (NSC 141540) for the treatment of patients with previously treated acute leukemia Cancer Clinical Trials 3(4): 325-328
Hiçsönmez, G.; Ozsoylu, S.; Tuncer, M.; Erer, B. 1988: High-dose intravenous methylprednisolone in the treatment of acute nonlymphoblastic leukemia with ocular involvement Turkish Journal of Pediatrics 30(3): 181-183
Cáp, J.; Foltinová, A.; Kaiserová, E.; Babusíková, O.; Jamárik, M.; Jasenková, M. 1998: Is T-cell acute lymphoblastic leukemia still a high risk leukemia in children? Neoplasma 45(3): 135-139
Sasazaki, Y.; Asami, K.; Utsumi, J. 1992: Transient subacute encephalopathy induced by high-dose methotrexate treatment in children with acute lymphoblastic leukemia and malignant lymphoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(11): 1851-1857
Balwierz, W.; Moryl-Bujakowska, A.; Skoczeń, S.; Pawińska, K.; Balcerska, A.; Płoszyńska, A.; Chybicka, A.; Dobaczewski, G.; Juszczak, K.; Wachowiak, J.; Derwich, K.; Kowalczyk, J.; Wiśniewska-Slusarz, H.; Matysiak, Mł.; Krauze, A.; Rokicka-Milewska, R.; Pawelec, K.; Sońta-Jakimczyk, D.; Łuszczyńska, A.; Tomaszewska, R.; Wysocki, M.; Styczyński, J.; Swiatkiewicz, V. 2003: Advances in the treatment of children with high risk acute lymphoblastic leukemia (ALL) treated with modified "NEW YORK" protocols between 1987 and 2002 Przeglad lekarski 60 Suppl. 5: 13-16
Sanz, M.A.; Martínez, J.; Borrego, D.; Martín-Aragonés, G.; Lorenzo, I.; Sanz, G.; Sayas, M.J.; Jarque, I.; Pastor, E.; Rafecas, J. 1987: High-dose cytosine arabinoside and mitoxantrone in high-risk acute nonlymphoblastic leukemia Seminars in Oncology 14(2 Suppl 1): 18-20
Ghaddar, H.M.; Plunkett, W.; Kantarjian, H.M.; Pierce, S.; Freireich, E.J.; Keating, M.J.; Estey, E.H. 1994: Long-term results following treatment of newly-diagnosed acute myelogenous leukemia with continuous-infusion high-dose cytosine arabinoside Leukemia 8(8): 1269-1274
Kantarjian, H.M.; Talpaz, M.; Andersson, B.; Khouri, I.; Giralt, S.; Rios, M.B.; Champlin, R.; Hester, J.; Deisseroth, A.B. 1994: High doses of cyclophosphamide, etoposide and total body irradiation followed by autologous stem cell transplantation in the management of patients with chronic myelogenous leukemia Bone Marrow Transplantation 14(1): 57-61
de Diego-Floreschapa, J.; López-Hernández, M.; Borbolla-Escoboza, J.R.; Trueba-Christy, E.; Carrillo-Rosales, T.; González-Avante, M. 1999: Long-term follow-up of 2 therapeutic programs for the treatment of high-risk childhood acute lymphoblastic leukemia. Experience at the 20 de Noviembre National Medical Center Gaceta Medica de Mexico 135(3): 253-258
Schmid, H.; Henze, G.; Schwerdtfeger, R.; Baumgarten, E.; Besserer, A.; Scheffler, A.; Serke, S.; Zingsem, J.; Siegert, W. 1993: Fractionated total body irradiation and high-dose VP-16 with purged autologous bone marrow rescue for children with high risk relapsed acute lymphoblastic leukemia Bone Marrow Transplantation 12(6): 597-602
Molcan, J.; Caplová, T.; Koniková, M.; Korinková, V.; Novotny, V.; Wajdickova, K. 1979: Noveril in high doses in the treatment of depression Agressologie: Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de l'Agression 20(D): 307-309
Duniewicz, M.; Mertenova, J.; Moravcova, E. 1971: Treatment of purulent meningitis with high doses of chloramphenicol Das Deutsche Gesundheitswesen 26(14): 657-660
Colbert, N.; Andrieu, J.M.; Bernard, J. 1980: Treatment of angioimmunoblastic lymphadenopathy with high doses of corticoids La Nouvelle Presse Medicale 9(18): 1305